Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Atsuko Nishida"'
Autor:
Keisuke Fukuchi, Kayoko Nanai, Hiroshi Yuita, Chikako Maru, Jun Tsukada, Masato Ishigami, Yoko Nagai, Yoko Nakano, Chigusa Yoshimura, Kozo Yoneda, Masato Amano, Kensuke Nakamura, Yoko Oda, Haruyuki Nishigohri, Shoji Yamamoto, Yusuke Ohnishi-Totoki, Koichiro Inaki, Hironobu Komori, Rika Nakano, Yoshiyuki Kanari, Atsuko Nishida, Yumi Matsui, Satoko Funo, Sayako Takahashi, Toshiaki Ohtsuka, Toshinori Agatsuma
Publikováno v:
Journal of Oncology. 2022:1-17
CD147 is an immunoglobulin-like receptor that is highly expressed in various cancers and involved in the growth, metastasis, and activation of inflammatory pathways via interactions with various functional molecules, such as integrins, CD44, and mono
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80437d30197dce139a45560ce288eb73
https://doi.org/10.1155/2022/3552793
https://doi.org/10.1155/2022/3552793
Publikováno v:
Annual Report of The Kansai Plant Protection Society. 60:95-97
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9ed9e6d8e13d37651ca057afccecb4ab
https://doi.org/10.4165/kapps.60.95
https://doi.org/10.4165/kapps.60.95
Autor:
Kozo Yoneda, Yoko Oda, Shoji Midori, Yumi Matsui, Masato Amano, Sayako Takahashi, Nakamura Kensuke, Kenji Murakami, Hironobu Komori, Rika Nakano, Naoyuki Makita, Atsuko Nishida, Yusuke Totoki, Koichiro Inaki, Masato Ishigami, Toshiaki Ohtsuka, Haruyuki Nishigohri, Satoko Funo, Kayoko Nanai, Yoshiyuki Kanari, Shoji Yamamoto, Chigusa Yoshimura, Jun Tsukada, Keisuke Fukuchi, Toshinori Agatsuma, Naomi Kasanuki, Yoko Nakano
Publikováno v:
Molecular Cancer Therapeutics. 18:B095-B095
CD147, a type I membrane protein, is highly expressed in various cancers and is involved in the growth, metastasis, and activation of inflammatory signals in cancer cells via interaction with various molecules, such as integrins, CD44, and monocarbox
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::da8911f84f90e83e14932e5f3b780388
https://doi.org/10.1158/1535-7163.targ-19-b095
https://doi.org/10.1158/1535-7163.targ-19-b095
Autor:
Atsushi Kurihara, Tomoko Ishizuka, Takashi Izumi, Toshihiko Ikeda, Hidetaka Sakurai, Kaori Nakahara, Izumi Fujimori, Yasushi Yoshigae, Atsuko Nishida
Publikováno v:
Drug Metabolism and Disposition. 40:374-380
Olmesartan medoxomil (OM) is a prodrug-type angiotensin II type 1 receptor antagonist. The OM-hydrolyzing enzyme responsible for prodrug bioactivation was purified from human plasma through successive column chromatography and was molecularly identif
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0114e7a4f2ae7a1aadd593039381a9b4
https://doi.org/10.1124/dmd.111.041475
https://doi.org/10.1124/dmd.111.041475